Graft vascularization is a critical rate-limiting step in skeletal stem cell-mediated posterolateral spinal fusion

Journal of Tissue Engineering and Regenerative Medicine

Volumn 4, Issue 4, 2010, Pages 273-283

  Giannicola, Giuseppe ^a   Ferrari, Emiliano ^a   Citro, Gennaro ^b   Sacchetti, Benedetto ^a   Corsi, Alessandro ^a   Riminucci, Mara ^a   Cinotti, Gianluca ^a   Bianco, Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Animal model; Histology; Posterolateral spinal fusion; Rabbit; Skeletal stem cells; Vascularization

Indexed keywords

BONE; CYTOLOGY; GRAFTING (CHEMICAL); GRAFTS;

ANIMAL MODEL; BONE FORMATION; CRITICAL RATES; OSTEOCONDUCTIVE; POSTEROLATERAL SPINAL FUSION; RABBIT; SKELETAL STEM CELL; SPINAL FUSION; STEM-CELL; VASCULARIZATION;

STEM CELLS;

BIOMATERIAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE CONDUCTION; BONE DEVELOPMENT; BONE MARROW CELL; BONE REGENERATION; CELL CULTURE; CONTROLLED STUDY; DENSITY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; MORPHOMETRICS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RABBIT; SPINE FUSION; STEM CELL TRANSPLANTATION; VASCULARIZATION; ANGIOGENESIS; ANIMAL; BIOLOGICAL MODEL; CHORISTOMA; CYTOLOGY; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; MOUSE; PATHOLOGY; PROCEDURES; RADIOGRAPHY; SKELETAL MUSCLE; SPINE; STEM CELL; STROMA CELL;

ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; CHORISTOMA; IMMUNOCOMPROMISED HOST; IMMUNOHISTOCHEMISTRY; MALE; MICE; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; RABBITS; SPINAL FUSION; SPINE; STEM CELL TRANSPLANTATION; STEM CELLS; STROMAL CELLS;

EID: 77953080941     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.238     Document Type: Article

References (40)

1. Ames CP, Smith JS, Preul MC, et al. 2005; Effect of recombinant human bone morphogenetic protein-2 in an experimental model of spinal fusion in a radiated area. Spine 30: 2585-2592.
2. Bianco P, Kuznetsov SA, Riminucci M, et al. 1998; Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsα-mutated skeletal progenitor cells. J Clin Invest 101: 1737-1744.
3. Bianco P, Robey PG, Simmons PJ. 2008; Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2: 313-319. (Pubitemid 351467394)
4. Boden SD, Martin GJ Jr, Morone M, et al. 1999; The use of coralline hydroxyapatite with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion. Spine 24: 320-327. (Pubitemid 29101940)
5. Boden SD, Schimandle JH, Hutton WC. 1995; An experimental lumbar intertransverse process spinal fusion model. Radiographic, histologic, and biomechanical healing characteristics. Spine 20: 412-420.
6. Bridwell KH, Anderson PA, Boden SD, et al. 2006; What's new in spine surgery. J Bone Joint Surg Am 88: 1897-1907.
7. Bruder SP, Fink DJ, Caplan AI. 1994; Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 56: 283-294.
8. Bruder SP, Kraus KH, Goldberg VM, et al. 1998; The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 80: 985-996.
9. Bucholz RW, Carlton A, Holmes RE. 1987; Hydroxyapatite and tricalcium phosphate bone graft substitutes. Orthop Clin North Am 18: 323-334. (Pubitemid 17061158)
10. Cinotti G, Patti AM, Vulcano A, et al. 2004; Experimental posterolateral spinal fusion with porous ceramics and mesenchymal stem cells. J Bone Joint Surg Br 86: 135-142. (Pubitemid 38128721)
11. Fernyhough JC, Schimandle JJ, Weigel MC, et al. 1992; Chronic donor site pain complicating bone graft harvesting from the posterior iliac crest for spinal fusion. Spine 17: 1474-1480.
12. Giannoni P, Mastrogiacomo M, Alini M, et al. 2008; Regeneration of large bone defects in sheep using bone marrow stromal cells. J Tissue Eng Regen Med 2: 253-262.
13. Goshima J, Goldberg VM, Caplan AI. 1991; Osteogenic potential of culture-expanded rat marrow cells as assayed in vivo with porous calcium phosphate ceramic. Biomaterials 12: 253-258.
14. Grauer JN, Vaccaro AR, Kato M, et al. 2004; Development of a New Zealand white rabbit model of spinal pseudarthrosis repair and evaluation of the potential role of OP-1 to overcome pseudarthrosis. Spine 29: 1405-1412. (Pubitemid 38879043)
15. Gundle R, Joyner CJ, Triffitt JT. 1995; Human bone tissue formation in diffusion chamber culture in vivo by bone-derived cells and marrow stromal fibroblastic cells. Bone 16: 597-601.
16. Guo X, Lee KM, Law LP, et al. 2002; Recombinant human bone morphogenetic protein-4 (rhBMP-4) enhanced posterior spinal fusion without decortication. J Orthop Res 20: 740-746. (Pubitemid 34822993)
17. Hsu WK, Wang JC. 2008; The use of bone morphogenetic protein in spine fusion. Spine J 8: 419-425.
18. Kon E, Muraglia A, Corsi A, et al. 2000; Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J Biomed Mater Res 49: 328-337. (Pubitemid 30030478)
19. Krebsbach PH, Kuznetsov SA, Satomura K, et al. 1997; Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63: 1059-1069. (Pubitemid 27190967)
20. Krebsbach PH, Mankani MH, Satomura K, et al. 1998; Repair of craniotomy defects using bone marrow stromal cells. Transplantation 66: 1272-1278. (Pubitemid 28551005)
21. Kuznetsov SA, Krebsbach PH, Satomura K, et al. 1997; Singlecolony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 12: 1335-1347. (Pubitemid 27375376)
22. Kuznetsov SA, Mankani MH, Robey PG. 2000; Effect of serum on human bone marrow stromal cells: ex vivo expansion and in vivo bone formation. Transplantation 70: 1780-1787.
23. Kuznetsov SA, Huang KE, Marshall GW, et al. 2008; Long-term stable canine mandibular augmentation using autologous bone marrow stromal cells and hydroxyapatite/tricalcium phosphate. Biomaterials 29: 4211-4216.
24. Magit DP, Maak T, Trioano N, et al. 2006; Healos/recombinant human growth and differentiation factor-5 induces posterolateral lumbar fusion in a New Zealand white rabbit model. Spine 31: 2180-2188. (Pubitemid 44337853)
25. Mankani MH, Kuznetsov SA, Fowler B, et al. 2001; In vivo bone formation by human bone marrow stromal cells: effect of carrier particle size and shape. Biotechnol Bioeng 72: 96-107.
26. Mankani MH, Kuznetsov SA, Avila NA, et al. 2004; Bone formation in transplants of human bone marrow stromal cells and hydroxyapatite-tricalcium phosphate: prediction with quantitative CT in mice. Radiology 230: 369-376. (Pubitemid 38133793)
27. Mankani MH, Kuznetsov SA, Shannon B, et al. 2006a; Canine cranial reconstruction using autologous bone marrow stromal cells. Am J Pathol 168: 542-550. (Pubitemid 43271152)
28. Mankani MH, Kuznetsov SA, Wolfe RM, et al. 2006b; In vivo bone formation by human bone marrow stromal cells: reconstruction of the mouse calvarium and mandible. Stem Cells 24: 2140-2149.
29. Martin GJ Jr, Boden SD, Titus L, et al. 1999; New formulations of demineralized bone matrix as a more effective graft alternative in experimental posterolateral lumbar spine arthrodesis. Spine 24: 637-645. (Pubitemid 29162905)
30. Minamide A, Tamaki T, Kawakami M, et al. 1999; Experimental spinal fusion using sintered bovine bone coatedwith type I collagen and recombinant human bone morphogenetic protein-2. Spine 24: 1863-1870. (Pubitemid 29449302)
31. Minamide A, Yoshida M, Kawakami M, et al. 2005; The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion. Spine 30: 1134-1138. (Pubitemid 40695922)
32. Muschler GF, Huber B, Ullman T, et al. 1993; Evaluation of bonegrafting materials in a new canine segmental spinal fusion model. J Orthop Res 11: 514-524. (Pubitemid 23234183)
33. Muschler GF, Nakamoto C, Griffith LG. 2004; Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 86: 1541-1558. (Pubitemid 38886548)
34. Nakajima T, Iizuka H, Tsutsumi S, et al. 2007; Evaluation of posterolateral spinal fusion using mesenchymal stem cells: differences with or without osteogenic differentiation. Spine 32: 2432-2436. (Pubitemid 350303688)
35. Namikawa T, Terai H, Suzuki E, et al. 2005; Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and β-tricalcium phosphate in a rabbit model. Spine 30: 1717-1722.
36. Sacchetti B, Funari A, Michienzi S, et al. 2007; Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131: 324-336.
37. Steinmann JC, Herkowitz HN. 1992; Pseudarthrosis of the spine. Clin Orthop Relat Res 284: 80-90.
38. Toribatake Y, Hutton WC, Tomita K, et al. 1998; Vascularization of the fusion mass in a posterolateral intertransverse process fusion. Spine 23: 1149-1154.
39. Wang JC, Kanim LE, Yoo S, et al. 2003; Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. J Bone Joint Surg Am 85: 905-911.
40. Zdeblick TA, Cooke ME, Kunz DN, et al. 1994; Anterior cervical discectomy and fusion using a porous hydroxyapatite bone graft substitute. Spine 19: 2348-2357.